Duration: (4:35) ?Subscribe5835 2025-02-28T03:05:45+00:00
Voiko Pfizerin koronalääke oikeasti muuttaa pandemian suuntaa? Tällaiset sen hyödyt ovat 💊
(4:35)
@pfizer CEO invests his pension back into Pfizer: ‘I’m all in’ #shorts
(25)
EVERYTHING you need to KNOW about the Pfizer Coronavirus Vaccine
(38)
Pentagon to Mandate Covid Vaccines After FDA Approves Pfizer Shot
(59)
Pfizer CEO is 'optimistic' on Covid vaccine for kids under age five
(5:3)
Fineprint: EU regulator clears way for use of Pfizer COVID-19 vaccine in Europe | World News
(2:5)
Pfizer, BioNTech Covid Vaccine Wins European Backing
(33)
Pfizer Global Vice President, Patrick van der Loo at the Biovac Institute
(4:50)
U.K. Regulator Approves Use Of Pfizer-BioNTech Covid Vaccine | NBC News NOW
(1:18)
Pfizer CEO Albert Bourla: Our 2025 focus is on pipeline
(5:51)
Pfizer CEO Albert Bourla On Covid Vaccine: Extended Interview | NBC Nightly News
(25:37)
Q. Why do you work at Pfizer?
(1:51)
Pfizer vaccine covid | How it works, efficacy and side effects
(11:8)
Pfizer CEO on need for fourth Covid vaccine dose, 'panvaccine' and more
(4:16)
Pfizer CEO Bourla on coronavirus vaccine timeline
(5:17)
How mRNA Vaccines work - Pfizer/Biontech, Moderna and co.
(2:43)
New surge of COVID-19 cases — How worried should we be?
(5:46)
Expert breaks down the latest on COVID-19 vaccine mixing and matching
(4:9)
Here's the key differences between Moderna and Pfizer vaccines: Leading vaccine researcher
(3:35)
Pfizer, BioNTech Seek EU Clearance for Covid-19 Vaccine
(5:27)
Pfizer - VP of Global Ops
(2:28)
#RealPfizer
(30)
Millions of parents waiting for regulators to decide if the Pfizer vaccine is safe for kids
(24)
How do the Pfizer and Moderna vaccines work?
(1:49)
96-Year-Old Receives Belgium's First Dose of the Pfizer/BioNTech's Vaccine
(1:1econd)
EU regulator recommends authorizing Pfizer's vaccine targeting XBB.1.5 variant
(3:42)
Kids could be fully vaxxed before Christmas as CDC OKs Pfizer shot
(2:55)
‘Win-win’: Pfizer vaccine profits benefits Portage
(2:8)
Pfizer vaccine OK'd
(29)
Pfizer: US regulators OK ‘priority review’